1
/
of
1
CJC-1295 No DAC + Ipamorelin 5/5mg – High-Purity Research Peptide Blend
CJC-1295 No DAC + Ipamorelin 5/5mg – High-Purity Research Peptide Blend
Regular price
£39.99 GBP
Regular price
Sale price
£39.99 GBP
Unit price
/
per
Currently 16 items are in stock!
Couldn't load pickup availability
Payment methods
CJC-1295 No DAC + Ipamorelin is a dual-peptide blend designed for laboratory research, combining two well-studied growth hormone secretagogues within a single lyophilised vial. Each 10mg vial contains 5mg of CJC-1295 No DAC (MOD GRF 1-29) and 5mg of Ipamorelin, supporting controlled investigation into growth hormone signalling and endocrine regulation.
To preserve stability and integrity, this peptide blend is supplied in freeze-dried form and independently verified at >99% purity (HPLC-tested). Every batch includes a full Certificate of Analysis (COA) to ensure transparency, consistency and reproducibility across research applications.
What is CJC-1295 No DAC + Ipamorelin?
CJC-1295 No DAC is a short-acting analogue of growth hormone releasing hormone (GHRH) that has been widely explored in research for its ability to stimulate pulsatile growth hormone release via GHRH receptor activation. Unlike DAC-modified variants, the No DAC form is designed for shorter-duration signalling, making it valuable for studies examining physiological GH patterns.
Ipamorelin is a selective growth hormone secretagogue pentapeptide studied for its ability to stimulate GH release while showing minimal interaction with other pituitary hormones. In laboratory settings, it is frequently paired with GHRH analogues due to its receptor selectivity and complementary signalling profile.
When combined, these peptides are commonly used in research to explore receptor synergy, growth hormone signalling dynamics and downstream metabolic responses.
Usage & Reconstitution
This peptide blend is supplied as a lyophilised solid to support long-term stability. Prior to reconstitution, allow the vial and solvent to reach ambient laboratory temperature. Reconstitute using bacteriostatic water or another suitable solvent in accordance with established research protocols. Avoid repeated freeze–thaw cycles. Reconstitution solutions are supplied separately.
⸻
Research Areas of Interest
Preclinical and laboratory investigations have explored this peptide blend across several research pathways, including:
Growth Hormone Signalling Research
Used to study pulsatile GH release and receptor-mediated endocrine signalling.
Endocrine Regulation Studies
Explored in models examining pituitary activity and hormonal coordination.
Metabolic & Cellular Recovery Research
Investigated for downstream effects on protein synthesis, cellular metabolism and recovery-related pathways.
This product is supplied strictly for laboratory research purposes only.
To preserve stability and integrity, this peptide blend is supplied in freeze-dried form and independently verified at >99% purity (HPLC-tested). Every batch includes a full Certificate of Analysis (COA) to ensure transparency, consistency and reproducibility across research applications.
What is CJC-1295 No DAC + Ipamorelin?
CJC-1295 No DAC is a short-acting analogue of growth hormone releasing hormone (GHRH) that has been widely explored in research for its ability to stimulate pulsatile growth hormone release via GHRH receptor activation. Unlike DAC-modified variants, the No DAC form is designed for shorter-duration signalling, making it valuable for studies examining physiological GH patterns.
Ipamorelin is a selective growth hormone secretagogue pentapeptide studied for its ability to stimulate GH release while showing minimal interaction with other pituitary hormones. In laboratory settings, it is frequently paired with GHRH analogues due to its receptor selectivity and complementary signalling profile.
When combined, these peptides are commonly used in research to explore receptor synergy, growth hormone signalling dynamics and downstream metabolic responses.
Usage & Reconstitution
This peptide blend is supplied as a lyophilised solid to support long-term stability. Prior to reconstitution, allow the vial and solvent to reach ambient laboratory temperature. Reconstitute using bacteriostatic water or another suitable solvent in accordance with established research protocols. Avoid repeated freeze–thaw cycles. Reconstitution solutions are supplied separately.
⸻
Research Areas of Interest
Preclinical and laboratory investigations have explored this peptide blend across several research pathways, including:
Growth Hormone Signalling Research
Used to study pulsatile GH release and receptor-mediated endocrine signalling.
Endocrine Regulation Studies
Explored in models examining pituitary activity and hormonal coordination.
Metabolic & Cellular Recovery Research
Investigated for downstream effects on protein synthesis, cellular metabolism and recovery-related pathways.
This product is supplied strictly for laboratory research purposes only.
